Previous close | 54.86 |
Open | 54.99 |
Bid | 53.15 x 1100 |
Ask | 53.70 x 800 |
Day's range | 52.90 - 55.00 |
52-week range | 46.93 - 93.80 |
Volume | |
Avg. volume | 201,773 |
Market cap | 1.297B |
Beta (5Y monthly) | 1.10 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.66 |
Earnings date | 27 July 2022 - 01 Aug 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 93.20 |
Establishment Labs Holdings Inc. ( NASDAQ:ESTA ) is possibly approaching a major achievement in its business, so we...
SANTA BARBARA, Calif., June 06, 2022--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that Juan José Chacón-Quirós, Founder and Chief Executive Officer, and Raj Denhoy, Chief Financial Officer, will present at the Jefferies Healthcare Conference on Wednesday, June 8, 2022 at 10:30 am Eastern Time.
Insiders who bought US$4.5m worth of Establishment Labs Holdings Inc. ( NASDAQ:ESTA ) stock in the last year have seen...